Literature DB >> 24129926

Plasma tau as a window to the brain-negative associations with brain volume and memory function in mild cognitive impairment and early Alzheimer's disease.

Ming-Jang Chiu1, Ya-Fang Chen, Ta-Fu Chen, Shieh-Yueh Yang, Fan-Pei Gloria Yang, Tien-Wen Tseng, Jen-Jie Chieh, Jia-Chun Rare Chen, Kai-Yuan Tzen, Mau-Sun Hua, Herng-Er Horng.   

Abstract

Neurofibrillary tangles are associated with cognitive dysfunction, and hippocampal atrophy with increased CSF tau markers. However, the plasma tau levels of Alzheimer's disease (AD) have not been well studied. We investigated plasma tau by using an immunomagnetic reduction assay in 20 patients with mild cognitive impairment (MCI) due to AD, 10 early AD dementia, and 30 healthy elders (HE). All received a 3D-brain MRI scan and a set of cognitive function test. We explored their relationships with both brain structure and cognitive functions. Images were analyzed to determine the brain volumes and gray matter densities. Patients with MCI or early AD had significantly increased plasma tau levels compared with HE. Plasma tau levels were negatively associated with the performance of logical memory, visual reproduction, and verbal fluency; also negatively associated with volume of total gray matter, hippocampus, amygdala; and gray matter densities of various regions. Regression analyses indicated that logical memory explained 0.394 and hippocampus volume predicted .608 of the variance of plasma tau levels, both P < 0.001. Education years were negatively associated with the gray matter densities of the supramarginal (r = -0.407), middle temporal gyrus (r = -0.40) and precuneus (r = -0.377; all P < 0.05) in HE; and negatively associated with plasma tau levels in patients (r = -0.626). We propose that plasma tau may serve as a window to both structure and function of the brain. Higher education is a protective factor against AD and is associated with lower plasma tau levels in patients.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  Alzheimer's disease; MRI volumetry; biomarker; hippocampus; immunomagnetic reduction; plasma total tau; voxel-based morphometry

Mesh:

Substances:

Year:  2013        PMID: 24129926      PMCID: PMC6869439          DOI: 10.1002/hbm.22390

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  44 in total

1.  Plasma tau protein in comatose patients after cardiac arrest treated with therapeutic hypothermia.

Authors:  E Mörtberg; H Zetterberg; J Nordmark; K Blennow; C Catry; H Decraemer; E Vanmechelen; S Rubertsson
Journal:  Acta Anaesthesiol Scand       Date:  2011-09-08       Impact factor: 2.105

Review 2.  Advances in functional and structural MR image analysis and implementation as FSL.

Authors:  Stephen M Smith; Mark Jenkinson; Mark W Woolrich; Christian F Beckmann; Timothy E J Behrens; Heidi Johansen-Berg; Peter R Bannister; Marilena De Luca; Ivana Drobnjak; David E Flitney; Rami K Niazy; James Saunders; John Vickers; Yongyue Zhang; Nicola De Stefano; J Michael Brady; Paul M Matthews
Journal:  Neuroimage       Date:  2004       Impact factor: 6.556

3.  Relationship between injury severity and serum tau protein levels in traumatic brain injured rats.

Authors:  Po-Chou Liliang; Cheng-Loong Liang; Kang Lu; Kuo-Wei Wang; Hui-Ching Weng; Ching-Hua Hsieh; Yu-Duan Tsai; Han-Jung Chen
Journal:  Resuscitation       Date:  2010-07-02       Impact factor: 5.262

4.  A voxel-based morphometric study of ageing in 465 normal adult human brains.

Authors:  C D Good; I S Johnsrude; J Ashburner; R N Henson; K J Friston; R S Frackowiak
Journal:  Neuroimage       Date:  2001-07       Impact factor: 6.556

5.  Diffusion tensor changes in patients with amnesic mild cognitive impairment and various dementias.

Authors:  Ta-Fu Chen; Chih-Chun Lin; Ya-Fang Chen; Hon-Man Liu; Mau-Sun Hua; Yung-Chien Huang; Ming-Jang Chiu
Journal:  Psychiatry Res       Date:  2009-05-12       Impact factor: 3.222

6.  Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.

Authors:  Tero Tapiola; Irina Alafuzoff; Sanna-Kaisa Herukka; Laura Parkkinen; Päivi Hartikainen; Hilkka Soininen; Tuula Pirttilä
Journal:  Arch Neurol       Date:  2009-03

Review 7.  Total and phosphorylated tau protein as biological markers of Alzheimer's disease.

Authors:  Harald Hampel; Kaj Blennow; Leslie M Shaw; Yvonne C Hoessler; Henrik Zetterberg; John Q Trojanowski
Journal:  Exp Gerontol       Date:  2009-10-22       Impact factor: 4.032

8.  Relation of education and occupation-based socioeconomic status to incident Alzheimer's disease.

Authors:  Anita Karp; Ingemar Kåreholt; Chengxuan Qiu; Tom Bellander; Bengt Winblad; Laura Fratiglioni
Journal:  Am J Epidemiol       Date:  2004-01-15       Impact factor: 4.897

9.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging.

Authors:  F Fazekas; J B Chawluk; A Alavi; H I Hurtig; R A Zimmerman
Journal:  AJR Am J Roentgenol       Date:  1987-08       Impact factor: 3.959

Review 10.  Education and dementia in the context of the cognitive reserve hypothesis: a systematic review with meta-analyses and qualitative analyses.

Authors:  Xiangfei Meng; Carl D'Arcy
Journal:  PLoS One       Date:  2012-06-04       Impact factor: 3.240

View more
  58 in total

Review 1.  Tau in neurodegenerative disease.

Authors:  Yong-Lei Gao; Nan Wang; Fu-Rong Sun; Xi-Peng Cao; Wei Zhang; Jin-Tai Yu
Journal:  Ann Transl Med       Date:  2018-05

Review 2.  Body fluid biomarkers in Alzheimer's disease.

Authors:  Huan Lu; Xi-Chen Zhu; Teng Jiang; Jin-Tai Yu; Lan Tan
Journal:  Ann Transl Med       Date:  2015-04

3.  On comparing 2 correlated C indices with censored survival data.

Authors:  Xiaoxia Han; Yilong Zhang; Yongzhao Shao
Journal:  Stat Med       Date:  2017-07-31       Impact factor: 2.373

4.  Inhibitory Control Deficits in Individuals with Amnestic Mild Cognitive Impairment: a Meta-Analysis.

Authors:  Rahel Rabi; Brandon P Vasquez; Claude Alain; Lynn Hasher; Sylvie Belleville; Nicole D Anderson
Journal:  Neuropsychol Rev       Date:  2020-03-12       Impact factor: 7.444

5.  Learnings about the complexity of extracellular tau aid development of a blood-based screen for Alzheimer's disease.

Authors:  Zhicheng Chen; David Mengel; Ashvini Keshavan; Robert A Rissman; Andrew Billinton; Michael Perkinton; Jennifer Percival-Alwyn; Aaron Schultz; Michael Properzi; Keith Johnson; Dennis J Selkoe; Reisa A Sperling; Purvish Patel; Henrik Zetterberg; Douglas Galasko; Jonathan M Schott; Dominic M Walsh
Journal:  Alzheimers Dement       Date:  2018-11-09       Impact factor: 21.566

6.  Association of Plasma Total Tau Level With Cognitive Decline and Risk of Mild Cognitive Impairment or Dementia in the Mayo Clinic Study on Aging.

Authors:  Michelle M Mielke; Clinton E Hagen; Alexandra M V Wennberg; David C Airey; Rodolfo Savica; David S Knopman; Mary M Machulda; Rosebud O Roberts; Clifford R Jack; Ronald C Petersen; Jeffrey L Dage
Journal:  JAMA Neurol       Date:  2017-09-01       Impact factor: 18.302

7.  Plasma Biomarkers of Alzheimer's Disease in African Americans.

Authors:  Kaancan Deniz; Charlotte C G Ho; Kimberly G Malphrus; Joseph S Reddy; Thuy Nguyen; Troy P Carnwath; Julia E Crook; John A Lucas; Neill R Graff-Radford; Minerva M Carrasquillo; Nilüfer Ertekin-Taner
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

Review 8.  Activation of the Brain to Postpone Dementia: A Concept Originating from Postmortem Human Brain Studies.

Authors:  Qiong-Bin Zhu; Ai-Min Bao; Dick Swaab
Journal:  Neurosci Bull       Date:  2019-02-05       Impact factor: 5.203

9.  Diagnostic and prognostic biomarkers for HAND.

Authors:  Kristen A McLaurin; Rosemarie M Booze; Charles F Mactutus
Journal:  J Neurovirol       Date:  2019-01-03       Impact factor: 2.643

10.  Combined plasma biomarkers for diagnosing mild cognition impairment and Alzheimer's disease.

Authors:  Ming-Jang Chiu; Shieh-Yueh Yang; Herng-Er Horng; Che-Chuan Yang; Ta-Fu Chen; Jen-Je Chieh; Hsin-Hsien Chen; Ting-Chi Chen; Chia-Shin Ho; Shuo-Fen Chang; Hao Chun Liu; Chin-Yih Hong; Hong-Chang Yang
Journal:  ACS Chem Neurosci       Date:  2013-10-23       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.